References
- Morel F, Chabardés D, Imbert-Teboul M. Heterogeneity of hormonal control in the distal nephron. Proc VII. Int Congr Nephrol. 1978; 209–16
- Düsing R, Herrmann R, Glänzer K, Vetter H, Overíack A, Kramer H J. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus. Clin Sci 1981; 61: 61–7
- Raij K, Perheentupa J, Härkonen M. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Scand J Clin Lab Invest 1974; 34: 177–84
- Cowley A W, Cushman W C, Quillen E W, Skelton M M, Langford H G. Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake. Hypertension 1981; 3(suppl I)I-93–I-100
- Padfield P L, Brown J J, Lever A F, Morton J J, Robertson J IS. Blood pressure in acute and chronic vasopressin excess. N Engl J Med 1981; 304: 1067–70
- Danielsen H, Pedersen E B. Renin-angiotensin-aldosterone system in exaggerated natriuresis of chronic glomerulonephritis. Scand J Clin Lab Invest, (in press)
- Pedersen E B, Danielsen H, Spencer E S. Effect of indapamide on renal plasma flow, glomerular filtration rate, and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543–7
- Robertson G L. The regulation of vasopressin function in health and disease. Rec Progr Horm Res 1977; 33: 333–74
- Gilman A G. A protein binding assay for adenosine 3′: 5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67: 305–12
- Bradley J V. Distribution-free statistical tests. Englewood Cliffs, Prentice-Hall 1968
- Broadus A E, Kaminsky N I, Hardman J G, Sutherland E W, Liddle G W. Kinetic parameters and renal clearances of plasma adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-mono-phosphate in man. J Clin Invest 1970; 49: 2222–36
- Handler J S. Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. Kidney Int 1981; 19: 831–8
- Katayama S, Itabashi A, Yamaji T. Prolonged antidiuresis by I-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production. Endocrinol Jpn 1980; 27: 363–70
- Epstein M, Hollenberg N K. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87: 411–17
- Helderman J H, Vestal R E, Rowe J W, Tobin J D, Andres R, Robertson G L. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: the impact of aging. J Gerontol 1978; 33: 39–47
- Schacht R G, Steele J M, Baldwin D S. Exaggerated natriuresis in the course of poststreptococcal glomerulonephritis. Nephron 1974; 13: 349–64
- Willassen Y, Ofstad J. Intrarenal pressure and sodium excretion in hypertension of chronic glomerulonephritis in humans. Hypertension 1983; 5: 375–84
- Chan W Y. Effects of prolonged administration of vasopressin on plasma sodium and renal excretion of electrolytes and water. J Pharmacol Exp Ther 1971; 178: 141–51
- Martinez-Maldonado M, Eknoyan G, Suki W N. Natriuretic effects of vasopressin and cyclic AMP: possible site of action in the nephron. Am J Physiol 1971; 220: 2013–20